Solace Biotch Product's Start with Letter "G"
•Download as PPT, PDF•
0 likes•370 views
Recommended
More Related Content
What's hot
Viewers also liked
Similar to Solace Biotch Product's Start with Letter "G"
Similar to Solace Biotch Product's Start with Letter "G" (20)
More from Solace Biotech Limited
More from Solace Biotech Limited (20)
Recently uploaded
Recently uploaded (20)
Solace Biotch Product's Start with Letter "G"
- 2. Name of BraNds start With alphaBet “G”
- 3. Glymon –G1 Glymon – G2 G
- 5. Glymon – G1 Bilayered Tablets Each bilayered tablet contains: Glimepiride 1 mg Metformin (sustained release) 500 mg Anti-diabetic
- 6. DESCRIPTION: Glimepiride The primary mechanism of action of glimepiride in lowering blood glucose appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. In addition, extra pancreatic effects may also play a role in the activity of sulphonylureas such as glimepiride. Metformin Metformin is an oral antihyperglyacemic drug used in the management of type 2 diabetes. It improves glucose tolerance in patients with type 2 diabetes (NIDDM). Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
- 8. Glymon – G2 Bilayered Tablets Each bilayered tablet contains: Glimepiride 2 mg Metformin (sustained release) 500 mg Anti-diabetic
- 9. DESCRIPTION: Glimepiride The primary mechanism of action of glimepiride in lowering blood glucose appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. In addition, extra pancreatic effects may also play a role in the activity of sulphonylureas such as glimepiride. Metformin Metformin is an oral antihyperglyacemic drug used in the management of type 2 diabetes. It improves glucose tolerance in patients with type 2 diabetes (NIDDM). Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
- 10. DESCRIPTION: Glimepiride The primary mechanism of action of glimepiride in lowering blood glucose appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. In addition, extra pancreatic effects may also play a role in the activity of sulphonylureas such as glimepiride. Metformin Metformin is an oral antihyperglyacemic drug used in the management of type 2 diabetes. It improves glucose tolerance in patients with type 2 diabetes (NIDDM). Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, improves insulin sensitivity by increasing peripheral glucose uptake and utilization.